Descargar PDF
1 / Páginas

Otros usuarios también vieron estos artículos

Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;
Gastroenterol Hepatol. 2024;47:463-72
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes Jesús Rivera-Esteban; Mònica Pons; Alejandra Planas; Ramiro Manzano-Nuñez; Cristina Hernández; Olga Simó-Servat; Jordi Bañeras; María José Soler; Daniel Seron; Anna Boixadera; Salvador Augustin; Rafael Simó; Ignacio Ferreira-González; Joan Genescà; Juan M. Pericàs;
Gastroenterol Hepatol. 2023;46:682-91
NAFLD and type 2 diabetes: A practical guide for the joint management Idoia Genua; Paula Iruzubieta; Juan Carlos Rodríguez-Duque; Antonio Pérez; Javier Crespo;
Gastroenterol Hepatol. 2023;46:815-25